A review of the additive health risk of cannabis and tobacco co-use

Drug and Alcohol Dependence

Volumn 166, Issue , 2016, Pages 6-12

  Meier, Ellen ^a   Hatsukami, Dorothy K ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Blunts; Cannabis; Co use; Dual use; E cigarettes; Nicotine; Tobacco

Indexed keywords

CANNABIS; CARBON MONOXIDE; CARCINOGEN; NICOTINE; TETRAHYDROCANNABINOL;

CANNABIS USE; CONCENTRATION (PARAMETERS); ELECTRONIC CIGARETTE; EXPOSURE; HEALTH HAZARD; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; SMOKING; TOBACCO USE; ADVERSE EFFECTS; CANNABIS SMOKING; COMORBIDITY; EPIDEMIOLOGY; HIGH RISK BEHAVIOR; RISK FACTOR; TOBACCO; TRENDS;

CANNABIS; CARBON MONOXIDE; COMORBIDITY; ELECTRONIC CIGARETTES; HUMANS; MARIJUANA SMOKING; NICOTINE; RISK FACTORS; RISK-TAKING; SMOKING; TOBACCO; TOBACCO PRODUCTS;

EID: 84979737498     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2016.07.013     Document Type: Review

References (47)

1. Agrawal, A., Budney, A.J., Lynskey, M.T., The co-occurring use and misuse of cannabis and tobacco: a review. Addiction (Abingdon, England) 107 (2012), 1221–1233.
2. Agrawal, A., Lynskey, M.T., Tobacco and cannabis co-occurrence: does route of administration matter?. Drug Alcohol Depend. 99 (2009), 240–247.
3. Agrawal, A., Wetherill, L., Dick, D.M., Xuei, X., Hinrichs, A., Hesselbrock, V., Kramer, J., Nurnberger, J.I. Jr., Schuckit, M., Bierut, L.J., Edenberg, H.J., Foroud, T., Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Am. J. Med. Genet. Part B: Neuropsychiatr. Genet. 150b (2009), 736–740.
4. Aung, A.T., Pickworth, W.B., Moolchan, E.T., History of marijuana use and tobacco smoking topography in tobacco-dependent adolescents. Addict. Behav. 29 (2004), 699–706.
5. Becker, J., Haug, S., Kraemer, T., Schaub, M.P., Feasibility of a group cessation program for co-smokers of cannabis and tobacco. Drug Alcohol Rev. 34 (2015), 418–426.
6. Becker, J., Haug, S., Sullivan, R., Schaub, M.P., Effectiveness of different Web-based interventions to prepare co-smokers of cigarettes and cannabis for double cessation: a three-arm randomized controlled trial. J. Med. Internet Res., 16, 2014, e273.
7. Belanger, R.E., Marclay, F., Berchtold, A., Saugy, M., Cornuz, J., Suris, J.C., To what extent does adding tobacco to cannabis expose young users to nicotine?. Nicotine Tob. Res. 15 (2013), 1832–1838.
8. CDC, 2015. Smoking & Tobacco Use: Fast Facts. http://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/. (accessed on 01.07.16).
9. Chen, X., Williamson, V.S., An, S.S., Hettema, J.M., Aggen, S.H., Neale, M.C., Kendler, K.S., Cannabinoid receptor 1 gene association with nicotine dependence. Arch. Gen. Psychiatry 65 (2008), 816–824.
10. Cooper, Z.D., Haney, M., Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts. Drug Alcohol Depend. 103 (2009), 107–113.
11. Earleywine, M., Barnwell, S.S., Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduct. J., 4, 2007, 11.
12. Etter, J.F., Electronic cigarettes and cannabis: an exploratory study. Eur. Addict. Res. 21 (2015), 124–130.
13. Haney, M., Bedi, G., Cooper, Z.D., Glass, A., Vosburg, S.K., Comer, S.D., Foltin, R.W., Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status. Biol. Psychiatry 73 (2013), 242–248.
14. Hartman, R.L., Brown, T.L., Milavetz, G., Spurgin, A., Gorelick, D.A., Gaffney, G., Huestis, M.A., Controlled cannabis vaporizer administration: blood and plasma cannabinoids with and without alcohol. Clin. Chem. 61 (2015), 850–869.
15. Hill, K.P., Toto, L.H., Lukas, S.E., Weiss, R.D., Trksak, G.H., Rodolico, J.M., Greenfield, S.F., Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: a pilot study. Am. J. Addict. 22 (2013), 233–238.
16. Hoffmann, D., Hoffmann, I., El-Bayoumy, K., The less harmful cigarette: a controversial issue: a tribute to Ernst L. Wynder. Chem. Res. Toxicol. 14 (2001), 767–790.
17. Izzotti, A., Pulliero, A., Molecular damage and lung tumors in cigarette smoke-exposed mice. Ann. N. Y. Acad. Sci. 1340 (2015), 75–83.
18. Jacobsen, L.K., Pugh, K.R., Constable, R.T., Westerveld, M., Mencl, W.E., Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent cannabis users. Biol. Psychiatry 61 (2007), 31–40.
19. Kim, H.R., Jung, M.H., Lee, S.Y., Oh, S.M., Chung, K.H., Marijuana smoke condensate induces p53-mediated apoptosis in human lung epithelial cells. J. Toxicol. Sci. 38 (2013), 337–347.
20. Klesges, R.C., Ebbert, J.O., Morgan, G.D., Sherrill-Mittleman, D., Asfar, T., Talcott, W.G., Debon, M., Impact of differing definitions of dual tobacco use: implications for studying dual use and a call for operational definitions. Nicotine Tob. Res. 13 (2011), 523–531.
21. Lee, D.C., Budney, A.J., Brunette, M.F., Hughes, J.R., Etter, J.F., Stanger, C., Treatment models for targeting tobacco use during treatment for cannabis use disorder: case series. Addict. Behav. 39 (2014), 1224–1230.
22. Lee, D.C., Budney, A.J., Brunette, M.F., Hughes, J.R., Etter, J.F., Stanger, C., Outcomes from a computer-assisted intervention simultaneously targeting cannabis and tobacco use. Drug Alcohol Depend. 155 (2015), 134–140.
23. Levine, A., Huang, Y., Drisaldi, B., Griffin, E.A. Jr., Pollak, D.D., Xu, S., Yin, D., Schaffran, C., Kandel, D.B., Kandel, E.R., Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine. Sci. Translat. Med., 3, 2011 107ra109.
24. Maertens, R.M., White, P.A., Williams, A., Yauk, C.L., A global toxicogenomic analysis investigating the mechanistic differences between tobacco and marijuana smoke condensates in vitro. Toxicology 308 (2013), 60–73.
25. Malouff, J.M., Rooke, S.E., Copeland, J., Experiences of marijuana-vaporizer users. Subst. Abuse 35 (2014), 127–128.
26. Messner, B., Bernhard, D., Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 509–515.
27. Moir, D., Rickert, W.S., Levasseur, G., Larose, Y., Maertens, R., White, P., Desjardins, S., A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem. Res. Toxicol. 21 (2008), 494–502.
28. Moolchan, E.T., Zimmerman, D., Sehnert, S.S., Zimmerman, D., Huestis, M.A., Epstein, D.H., Recent marijuana blunt smoking impacts carbon monoxide as a measure of adolescent tobacco abstinence. Subst. Use Misuse 40 (2005), 231–240.
29. Morean, M.E., Kong, G., Camenga, D.R., Cavallo, D.A., Krishnan-Sarin, S., High school students' use of electronic cigarettes to vaporize cannabis. Pediatrics 136 (2015), 611–616.
30. Nemeth-Coslett, R., Henningfield, J.E., O'Keeffe, M.K., Griffiths, R.R., Effects of marijuana smoking on subjective ratings and tobacco smoking. Pharmacol. Biochem. Behav. 25 (1986), 659–665.
31. Panlilio, L.V., Zanettini, C., Barnes, C., Solinas, M., Goldberg, S.R., Prior exposure to THC increases the addictive effects of nicotine in rats. Neuropsychopharmacology 38 (2013), 1198–1208.
32. Penetar, D.M., Kouri, E.M., Gross, M.M., McCarthy, E.M., Rhee, C.K., Peters, E.N., Lukas, S.E., Transdermal nicotine alters some of marihuana's effects in male and female volunteers. Drug Alcohol Depend. 79 (2005), 211–223.
33. Peters, E.N., Budney, A.J., Carroll, K.M., Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. Addiction (Abingdon, England) 107 (2012), 1404–1417.
34. Peters, E.N., Schwartz, R.P., Wang, S., O'Grady, K.E., Blanco, C., Psychiatric, psychosocial, and physical health correlates of co -occurring cannabis use disorders and nicotine dependence. Drug Alcohol Depend., 2014, 0, 10.1016/j.drugalcdep.2013.1010.1003.
35. Rabin, R.A., George, T.P., A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use. Am. J. Addict. 24 (2015), 105–116.
36. Rahman, M.A., Hann, N., Wilson, A., Mnatzaganian, G., Worrall-Carter, L., E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis. PLoS One, 10, 2015, e0122544.
37. Ramo, D.E., Liu, H., Prochaska, J.J., Tobacco and marijuana use among adolescents and young adults: a systematic review of their co-use. Clin. Psychol. Rev. 32 (2012), 105–121.
38. RCP, Nicotine Without Smoke: Tobacco Harm Reduction. 2016, RCP, London.
39. Schauer, G.L., Berg, C.J., Kegler, M.C., Donovan, D.M., Windle, M., Assessing the overlap between tobacco and marijuana: trends in patterns of co-use of tobacco and marijuana in adults from 2003 to 2012. Addict. Behav. 49 (2015), 26–32.
40. Schauer, G.L., King, B.A., Bunnell, R.E., Promoff, G., McAfee, T.A., Toking, vaping, and eating for health or fun: marijuana use patterns in adults, U.S. Am. J. Prev. Med. 50 (2014), 1–8.
41. Sherman, M.P., Aeberhard, E.E., Wong, V.Z., Simmons, M.S., Roth, M.D., Tashkin, D.P., Effects of smoking marijuana, tobacco or cocaine alone or in combination on DNA damage in human alveolar macrophages. Life Sci. 56 (1995), 2201–2207.
42. Simmons, M.S., Tashkin, D.P., The relationship of tobacco and marijuana smoking characteristics. Life Sci. 56 (1995), 2185–2191.
43. Valjent, E., Mitchell, J.M., Besson, M.J., Caboche, J., Maldonado, R., Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. Br. J. Pharmacol. 135 (2002), 564–578.
44. Van Dam, N.T., Earleywine, M., Pulmonary function in cannabis users: support for a clinical trial of the vaporizer. Int. J. Drug Policy 21 (2010), 511–513.
45. Van Vunakis, H., Tashkin, D.P., Simmons, M., Clark, V.A., Decreased serum cotinine levels in smokers of both tobacco and marijuana as compared with smokers of tobacco only. Pharmacol. Biochem. Behav. 30 (1988), 895–898.
46. Vandrey, R.G., Budney, A.J., Hughes, J.R., Liguori, A., A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. Drug Alochol Depend. 92 (2008), 48–54.
47. WHO, Management of Substance Abuse: Cannabis. 2016, WHO, Geneva ( http://www.who.int/substance_abuse/facts/cannabis/en/. Accessed on 01.07.16).